Anna Ferrer
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Álex Casalots (1 shared paper)Eugeni Saigí (1 shared paper)Xavier Serra‐Aracil (1 shared paper)E. Dotor (1 shared paper)Anna Ruiz (1 shared paper)Carles Pericay (1 shared paper)Juhani Vilpo (3 shared papers)Sakari Knuutila (3 shared papers)
- Journals
- British Journal of Haematology (2 papers)BMC Genomics (2 papers)Oncology Reports (1 paper)CHEST Journal (1 paper)PLoS ONE (1 paper)
- Partner nations
- SpainUnited StatesFinland
In The Last Decade
Anna Ferrer
10 papers receiving 488 citations
Peers
Comparison fields: 5 of 53
- Genetics 190
- Cancer Research 180
- Pathology and Forensic Medicine 193
- Immunology 104
- Hematology 46
Countries citing papers authored by Anna Ferrer
This map shows the geographic impact of Anna Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ferrer more than expected).
Fields of papers citing papers by Anna Ferrer
This network shows the impact of papers produced by Anna Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ferrer. The network helps show where Anna Ferrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Ferrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 142 | |
| 2 | 2002 | 142 | |
| 3 | 2003 | 89 | |
| 4 | 2004 | 30 | |
| 5 | 2013 | 26 | |
| 6 | 2009 | 23 | |
| 7 | 2011 | 18 | |
| 8 | 2013 | 12 | |
| 9 | Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis. | 2003 | 12 |
| 10 | 2017 | 5 | |
| 11 | 2024 | 0 |
About Anna Ferrer
Anna Ferrer is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Genetics, Immunology and Cancer Research, having authored 11 papers that have together received 499 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), MicroRNA in disease regulation (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Cancer-related molecular mechanisms research (2 papers), Water Treatment and Disinfection (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Genetics (190 citations), Cancer Research (180 citations), Pathology and Forensic Medicine (193 citations), Immunology (104 citations) and Hematology (46 citations). Anna Ferrer has collaborated with scholars based in Spain, United States and Finland. Frequent co-authors include Álex Casalots, Eugeni Saigí, Xavier Serra‐Aracil, E. Dotor, Anna Ruiz, Carles Pericay, Juhani Vilpo, Sakari Knuutila, Yan Aalto and Bálint Nagy. Their work appears in journals such as British Journal of Haematology, BMC Genomics, Oncology Reports, CHEST Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.